- Home
- DYN vs DGII Comparison
DYN vs DGII Comparison
Compare DYN & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- DGII
- Stock Information
- Founded
- DYN 1984
- DGII 1985
- Country
- DYN United States
- DGII United States
- Employees
- DYN N/A
- DGII N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- DGII Computer peripheral equipment
- Sector
- DYN Health Care
- DGII Technology
- Exchange
- DYN Nasdaq
- DGII Nasdaq
- Market Cap
- DYN 1.4B
- DGII 1.2B
- IPO Year
- DYN 2020
- DGII N/A
- Fundamental
- Price
- DYN $9.67
- DGII $35.02
- Analyst Decision
- DYN Strong Buy
- DGII Hold
- Analyst Count
- DYN 15
- DGII 4
- Target Price
- DYN $43.60
- DGII $33.50
- AVG Volume (30 Days)
- DYN 2.8M
- DGII 143.2K
- Earning Date
- DYN 08-11-2025
- DGII 08-06-2025
- Dividend Yield
- DYN N/A
- DGII N/A
- EPS Growth
- DYN N/A
- DGII 196.64
- EPS
- DYN N/A
- DGII 1.13
- Revenue
- DYN N/A
- DGII $418,624,000.00
- Revenue This Year
- DYN N/A
- DGII $1.81
- Revenue Next Year
- DYN N/A
- DGII $4.34
- P/E Ratio
- DYN N/A
- DGII $30.93
- Revenue Growth
- DYN N/A
- DGII N/A
- 52 Week Low
- DYN $6.36
- DGII $20.17
- 52 Week High
- DYN $47.45
- DGII $37.07
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- DGII 64.07
- Support Level
- DYN $10.00
- DGII $32.74
- Resistance Level
- DYN $10.74
- DGII $33.61
- Average True Range (ATR)
- DYN 0.88
- DGII 0.71
- MACD
- DYN -0.48
- DGII -0.06
- Stochastic Oscillator
- DYN 0.53
- DGII 81.89
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.